Form 8-K CHARLES RIVER LABORATORI For: May 04

Go back to Form 8-K CHARLES RIVER LABORATORI For: May 04

Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts FY16 EPS Outlook

May 4, 2016 7:33 AM EDT

Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.98, $0.08 better than the analyst estimate of $0.90. Revenue for the quarter came in at $354.9 million versus the consensus estimate of $354.91 million.

GUIDANCE:

Charles River Laboratories sees FY2016 EPS of $4.32-$4.45, versus the... More